METHYLTESTOSTERONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methyltestosterone, and what generic alternatives are available?
Methyltestosterone is a drug marketed by Heather, Impax Labs Inc, Novitium Pharma, Impax Labs, Lilly, Purepac Pharm, Pvt Form, Tablicaps, Usl Pharma, Inwood Labs, Kv Pharm, Lannett, Parke Davis, Watson Labs, and West Ward. and is included in twenty-eight NDAs.
The generic ingredient in METHYLTESTOSTERONE is methyltestosterone. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyltestosterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methyltestosterone
A generic version of METHYLTESTOSTERONE was approved as methyltestosterone by IMPAX LABS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHYLTESTOSTERONE?
- What are the global sales for METHYLTESTOSTERONE?
- What is Average Wholesale Price for METHYLTESTOSTERONE?
Summary for METHYLTESTOSTERONE
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 28 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,401 |
| DailyMed Link: | METHYLTESTOSTERONE at DailyMed |
Recent Clinical Trials for METHYLTESTOSTERONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
| Solvay Pharmaceuticals | Phase 2 |
Pharmacology for METHYLTESTOSTERONE
| Drug Class | Androgen |
| Mechanism of Action | Androgen Receptor Agonists |
Medical Subject Heading (MeSH) Categories for METHYLTESTOSTERONE
Anatomical Therapeutic Chemical (ATC) Classes for METHYLTESTOSTERONE
US Patents and Regulatory Information for METHYLTESTOSTERONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| West Ward | METHYLTESTOSTERONE | methyltestosterone | TABLET;ORAL | 084331-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Tablicaps | METHYLTESTOSTERONE | methyltestosterone | TABLET;ORAL | 080313-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| West Ward | METHYLTESTOSTERONE | methyltestosterone | TABLET;ORAL | 084331-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Tablicaps | METHYLTESTOSTERONE | methyltestosterone | TABLET;ORAL | 085270-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
